DYAI Competitors & Alternatives
Compare Dyadic International Inc with similar stocks in the same industry
Biotechnology
DYAI
Main Stock$0.35
Tradestie Score
55
Market Cap
$47.04M
Revenue Growth
0.0%
Analyst Upside
+1471.0%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.23
|
$154.27M | - | 41 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.87
|
$133.50M | - | 31 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.67
|
$117.07M | - | 30 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$4.81
|
$114.01M | - | 57 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$30.62
|
$110.20M | - | 41 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.55
|
$97.42M | - | 50 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.22
|
$84.52M | - | 40 | Compare |
|
BYSI
BeyondSpring Inc. Ordinary Shares
|
$0.60
|
$72.18M | - | 28 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.07
|
$67.94M | - | 52 | Compare |
|
EDSA
Edesa Biotech, Inc. Common Shares
|
$2.08
|
$18.87M | - | 50 | Compare |
More DYAI Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry